59 / 156
475
55. Kelekci S, Yazicioglu HF, Yilmaz B, Aygün M, Omeroglu RE. Cardiac
rhabdomyoma with tuberous sclerosis: a case report. J Reprod Med.
2005 Jul; 50(7):550-2.
56. Tworetzky W, McElhinney DB, Margossian R, Moon-Grady AJ,
Sallee D, Goldmuntz E, van der Velde ME, Silverman NH, Allan LD.
Association between cardiac tumors and tuberous sclerosis in the
fetus and neonate. Am J Cardiol. 2003 Aug 15; 92(4):487-9.
57. Mühler MR, Rake A, Schwabe M, Schmidt S, Kivelitz D, Chaoui R,
et al. Value of fetal cerebral MRI in sonographically proven cardiac
rhabdomyoma. Pediatr Radiol. 2007 May; 37(5):467-74.
58. Friedman AH, Copel JA, Kleinman CS. Fetal echocardiography and
fetal cardiology: indication, diagnosis and management. Semin
Perinatol 1993; 17: 76-88.
59. Meijboom EJ, van Engelen AD, van de Beek EW, Weijtens O,
Lautenschutz JM, Benatar AA. Fetal arrhythmias. Curr Opin Cardiol
1994; 9: 97-102.
60. Jaeggi E, Öhman A. Fetal and Neonatal Arrhythmias. Clin Perinatol.
2016 Mar;43(1):99-112.
61. Ferrer PL, Quetel T, Bezjian A, Gelband H. Outcome of fetal
and perinatal cardiac arrhythmias. A seven years experience. J
Ultrasound Med 1991; 10:S1-S104.
62. Guntheroth WG, Cyr DR, Shields LE, Nghiem HV. Rate-based
management of fetal supraventricular tachycardia. J Ultrasound
Med. 1996; 15: 453-8.
63. Allan LD, Chita K, Sharland G, Maxwell D, Priestley K. Flecainide in
the treatment of the fetal tachycardias. Br Heart J 1991; 65: 46-8.
64. Hasbun J, Muñoz H, Díaz C, Oyarzún R, Hernández I. Diagnóstico
y tratamiento antenatal de taquicardia supraventricular fetal.
Revista Chilena de Obstetricia y Ginecología. 61(2): 116-119.
1996.
65. Perry JC, Ayres N, Carpenter R. Fetal supraventricular tachycardia
treated with flecainide acetate. 1991; 118:303-5.
66. Sepúlveda C, Toche P, Muñoz H, Hernández I. Bloqueo cardíaco
congénito en hijo de madre con anticuerpos anti-Ro (SSA) y anti La
(SSB). Revista del Hospital Clínico Universidad de Chile. 2000.
67. Teng CE, Caldwell K, Feit S, Chang E, Buyon J. Subclass distribution
of maternal and neonatal anti-Ro (SSA) and La (SSB) antibodies in
congenital heart block. J Rheumatol 1996; 23: 925-32.
68. Weber HS, Myers JL. Maternal collagen vascular disease
associated with fetal heart block and degenerative changes of the
atrioventricular valves. Pediatr Cardiol 1994; 15: 204-6.
69. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA.
Perinatal outcome of fetal complete atrioventricular block: a
multicenter experience. J Am Coll Cardiol 1991; 91: 1360-6.
70. Kaaja R, Julkunen H, Ammala P, Teppo AM, Kurki P. Congenital
heart block: successful prophylactic treatment with intravenous
gamma globulin and corticosteroid therapy. Am J Obstet Gynecol
1991; 165: 1333-4.
71. AbuhamadA,ChaouiR.APracticalGuidetoFetalEchocardiography:
Normal and Abnormal Hearts, Lippincott Williams & Wilkins, 2nd
ed. Philadelphia, 2010.
72. Gournay V. The ductus arteriosus: physiology, regulation, and
functional and congenital anomalies. Arch Cardiovasc Dis. 2011
Nov;104(11):578-85. doi: 10.1016/j.acvd.2010.06.006. Epub
2010 Sep 21.
73. S. Saeed, S.N. Hyder, M. Sadiq, Anatomical variations of pulmonary
artery and asso- ciated cardiac defects in Tetralogy of Fallot, J. Coll.
Physicians Surg. Pak. 2009: 211–214.
74. Gardiner, C. Belmar, G. Tulzer, A. Barlow, L. Pasquini, et al,
Morphologic and func- tional predictors of eventual circulation
in the fetus with pulmonary atresia or critical pulmonary stenosis
with intact septum, J. Am. Coll. Cardiol. 2008: 1299–1308.
75. Ewigman BG, Crane JP, Frigolleto FD, et al. Effect of prenatal
ultrasound screening in perinatal outcome. N Engl J Med. 1993.
329, 21-7.
76. Luck CA. Value of routine ultrasound screening at 19 weeks: a four
year study of 8849 deliveries. 1992. 304, 1474-8.
77. Copel JA. Pilu G, Kleinman CS: Congenital heart disease and
extracardiac anomalies: Association and indications for fetal
echocadiography. Am. J. Obstet. Gynecol. 1986; 154: 1121.
78. Vergani P, Mariani S, Ghidini A, et al. Screening for congenital heart
disease with the 4-chamber view of the fetal heart. 1992. Am J
Obstet Gynecol, 167, 1000-3.
79. Bromley B, Estroff JA, Sanders SP, et al. Fetal echocardiography
accuracy and limitations in a population at high and low risk for
heart defects. 1992. Am J Obstet Gynecol, 166, 1473-81.
80. Muñoz H, Loureiro O, Brugere S, Hasbun JH, Walton R, et al:
Ecocardiografía fetal III: Diagnóstico de alteraciones estructurales
y del ritmo. Revista Chilena de Obstetricia y Ginecología. 1992.
57(1): 16-22.
81. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH.
Screening for chromosomal abnormalities at 10-14 weeks: the
role of ductus venosus blood flow. Ultrasound Obstet Gynecol
1998; 12: 380-384.
82. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Cardiac defects in chromosomally normal fetuses with abnormal
ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet
Gynecol 1999; 14: 307-310.
83. Hyett JA, Moscoso G, Papanagiotu G, Perdu M, Nicolaides KH.
Abnormalities of the great arteries in chromosomally normal
fetuses with increased nuchal translucency thickness at 11-13
weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 245-250.
84. Carvalho JS. Nuchal translucency, ductus venosus and congenital
heart disease: an important association - a cautious analysis.
Ultrasound Obstet Gynecol 1999; 14: 302-306.
85. Favre R, Y. Cherif, M. Kohler, A. Kohler, M.-C. Hunsinger, et al. The
role of fetal nuchal translucency and ductus venosus Doppler at
11-14 weeks of gestation in the detection of major congenital
heart defects. Ultrasound in Obstetrics and Gynecology. Volume
21, Issue 3, 2003. Pages: 239-243.
86. Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K. Ductus
venosus Doppler in fetuses with cardiac defects and increased
nuchal translucency thickness. Ultrasound Obstet Gynecol. 2008
Mar; 31(3):256-60.
87. N. Persico, J. Moratalla*, C. M. LombardiI‡, V. Zidere, L. Allan and
K. H. Nicolaides. Fetal echocardiography at 11–13 weeks by
transabdominal high-frequency ultrasound. Ultrasound Obstet
Gynecol 2011; 37: 296–301.
[Diagnóstico y manejo prenatal de patología cardíaca fetal - Dr. Hernán Muñoz y cols.]